Achieving high concentrations of sunitinib in tumors is linked to improved survival
A strategy for giving intermittent, high doses of the anti-cancer drug sunitinib is well-tolerated by patients with advanced cancer and increases concentrations of the drug in tumours, which is associated with improved survival, ...
Oct 24, 2020
0
3